These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

727 related items for PubMed ID: 17949785

  • 1. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [Abstract] [Full Text] [Related]

  • 2. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, Morita M, Yasumoto K.
    Cancer; 2006 May 15; 106(10):2190-9. PubMed ID: 16598757
    [Abstract] [Full Text] [Related]

  • 3. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
    Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH.
    Carcinogenesis; 2004 Nov 15; 25(11):2165-71. PubMed ID: 15231689
    [Abstract] [Full Text] [Related]

  • 4. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 5. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
    Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L.
    Cancer Res; 1999 Oct 01; 59(19):4798-803. PubMed ID: 10519387
    [Abstract] [Full Text] [Related]

  • 6. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
    Zhu LQ, Diao LM, Chen DJ, Li HG, Liu X, Zou ZY, Li BY, Wang M, Liu MQ.
    Ai Zheng; 2003 Jun 01; 22(6):571-4. PubMed ID: 12948402
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma.
    Tomizawa Y, Nakajima T, Kohno T, Saito R, Yamaguchi N, Yokota J.
    Cancer Res; 1998 Dec 01; 58(23):5478-83. PubMed ID: 9850082
    [Abstract] [Full Text] [Related]

  • 8. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA, Gorgoulis VG, Mariatos G, Zacharatos P, Kotsinas A, Liloglou T, Foukas P, Kanavaros P, Kastrinakis NG, Vassilakopoulos T, Vogiatzi T, Field JK, Kittas C.
    J Pathol; 2001 Jan 01; 193(1):55-65. PubMed ID: 11169516
    [Abstract] [Full Text] [Related]

  • 9. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L, Khan MA, Freedman AN, Gemma A, Rusin M, Guinee DG, Bennett WP, Caporaso NE, Fleming MV, Travis WD, Colby TV, Trastek V, Pairolero PC, Tazelaar HD, Midthun DE, Liotta LA, Harris CC.
    Cancer Res; 1998 Jun 15; 58(12):2533-6. PubMed ID: 9635574
    [Abstract] [Full Text] [Related]

  • 10. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma.
    Maruyama R, Sugio K, Yoshino I, Maehara Y, Gazdar AF.
    Cancer; 2004 Apr 01; 100(7):1472-7. PubMed ID: 15042681
    [Abstract] [Full Text] [Related]

  • 11. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S.
    Cancer Res; 1998 Nov 15; 58(22):5032-7. PubMed ID: 9823304
    [Abstract] [Full Text] [Related]

  • 12. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
    Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH.
    J Clin Oncol; 2004 Jun 15; 22(12):2363-70. PubMed ID: 15197197
    [Abstract] [Full Text] [Related]

  • 13. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
    Kim JS, Kim JW, Han J, Shim YM, Park J, Kim DH.
    Cancer Res; 2006 Apr 15; 66(8):4049-54. PubMed ID: 16618724
    [Abstract] [Full Text] [Related]

  • 14. Expression of glutathione S-transferase pi and glutathione synthase correlates with survival in early stage non-small cell carcinomas of the lung.
    Allen TC, Granville LA, Cagle PT, Haque A, Zander DS, Barrios R.
    Hum Pathol; 2007 Feb 15; 38(2):220-7. PubMed ID: 17234469
    [Abstract] [Full Text] [Related]

  • 15. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
    Hastürk S, Kemp B, Kalapurakal SK, Kurie JM, Hong WK, Lee JS.
    Cancer; 2002 Feb 15; 94(4):1023-31. PubMed ID: 11920472
    [Abstract] [Full Text] [Related]

  • 16. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.
    J Pathol; 2006 Oct 15; 210(2):192-204. PubMed ID: 16915569
    [Abstract] [Full Text] [Related]

  • 17. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
    Rohr UP, Rehfeld N, Geddert H, Pflugfelder L, Bruns I, Neukirch J, Rohrbeck A, Grote HJ, Steidl U, Fenk R, Opalka B, Gabbert HE, Kronenwett R, Haas R.
    Clin Cancer Res; 2005 Jan 01; 11(1):180-5. PubMed ID: 15671544
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M, Sugiura T, Ariyoshi Y, Mitsudomi T, Takahashi T.
    Clin Cancer Res; 1997 Jul 01; 3(7):1051-8. PubMed ID: 9815783
    [Abstract] [Full Text] [Related]

  • 19. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 01; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 20. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
    Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Minamiya Y, Ogawa J.
    Clin Cancer Res; 2005 Jul 15; 11(14):5084-9. PubMed ID: 16033821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.